Clinical Trials for Acute Myeloid Leukemia, in Relapse

Find clinical trials for acute myeloid leukemia, in relapse. Discover research opportunities and treatment options in your area.

23 Active Trials Found

Showing 23 trials on this page

Page 1 of 2

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

NCT ID: NCT06459024

This clinical trial is focused on understanding the experiences of patients with acute myeloid leukemia (AML) who have either relapsed (the cancer returned after treatment) or are refractory (the c...

Recruiting

Type: observational Locations: Roma, Rm, Italy, Como, Co, Italy +29 more

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT ID: NCT04716452

This clinical trial is studying a treatment called C6 Ceramide NanoLiposome (CNL) to see if it can help improve the effectiveness of standard cancer treatments for patients with relapsed or refract...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Hershey, Pennsylvania, United States +1 more

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

NCT ID: NCT06552416

This clinical trial is investigating a new treatment called MT-401-OTS for patients with relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). It aims to see how safe and effect...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Kansas City, Kansas, United States

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

NCT ID: NCT06680752

This clinical trial is studying a new treatment called ARD103 CAR-T therapy for patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to f...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Charlotte, North Carolina, United States +1 more

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

NCT ID: NCT05735184

This clinical trial is investigating a new treatment called ziftomenib when used together with other medications for patients with a type of blood cancer known as acute myeloid leukemia (AML). The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Minneapolis, Minnesota, United States +50 more

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

NCT ID: NCT07011004

This clinical trial is studying a new treatment combining special immune cells called natural killer (NK) cells with a medication called atezolizumab for people with acute myeloid leukemia (AML) wh...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

NCT ID: NCT06017258

This clinical trial is investigating a new treatment called CD371-YSNVZ-IL18 CAR T cells for people with a type of blood cancer known as Acute Myeloid Leukemia (AML), specifically for those whose c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Middletown, New Jersey, United States, Montvale, New Jersey, United States +5 more

Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

NCT ID: NCT05949125

This clinical trial is investigating a new treatment called Allo-RevCAR01-T-CD123 for patients with certain types of blood cancers, specifically Acute Myeloid Leukemia (AML) that has either come ba...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ulm, , Germany, Hannover, , Germany +10 more

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

NCT ID: NCT05124288

This clinical trial is looking at how the immune system affects relapses of Acute Myeloid Leukemia (AML) in patients who have undergone a specific type of treatment called allogeneic hematopoietic ...

Recruiting

Type: observational Locations: Milan, Milano, Italy

A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS

NCT ID: NCT06372717

This clinical trial is looking at a new treatment called APL-4098, both on its own and combined with another medication called azacitidine. The goal is to see how safe and effective these treatment...

Recruiting

Phase: PHASE1 Type: interventional Locations: Perth, Western Australia, Australia, Melbourne, Victoria, Australia +5 more

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

NCT ID: NCT06906380

This clinical trial is looking at the long-term safety of a treatment called ARD103 CAR-T cell therapy for patients who have certain types of blood cancers, specifically acute myeloid leukemia (AML...

Not yet recruiting

Type: observational

Off-the-shelf CD123 CAR-NK for R/R AML

NCT ID: NCT06201247

This clinical trial is studying a new treatment called JD123 injection, which uses specially engineered immune cells (CAR-NK cells) to target and fight acute myeloid leukemia (AML) that has either ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Beijing, Beijing, China

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

NCT ID: NCT05190471

This clinical trial is studying a new treatment called BP1002 for adults with a type of blood cancer known as refractory or relapsed Acute Myeloid Leukemia (AML). This means the cancer has not resp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +2 more

CD123 Redirected T Cells for AML in Pediatric Subjects

NCT ID: NCT04678336

This clinical trial is studying a new treatment for children and young adults with relapsed or hard-to-treat Acute Myeloid Leukemia (AML). The treatment involves using specially modified immune cel...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

KPT-9274 in Patients with Relapsed and Refractory Acute Myeloid Leukemia

NCT ID: NCT04914845

This clinical trial is studying a new oral medication called KPT-9274 to see how safe it is for patients with relapsed or refractory acute myeloid leukemia (AML), which means that their cancer has ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Aurora, Colorado, United States, Aurora, Colorado, United States

Venetoclax to Augment Epigenetic Modification and Chemotherapy

NCT ID: NCT05317403

This clinical trial is studying a new way to treat patients with acute myeloid leukemia (AML) who are either experiencing a relapse or have not responded to previous treatments. The researchers wan...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States

PLAT-08: a Study of SC-DARIC33 CAR T Cells in Pediatric and Young Adults with Relapsed or Refractory CD33+ AML

NCT ID: NCT05105152

The PLAT-08 clinical trial is studying a new type of treatment for young people with a specific form of leukemia called acute myeloid leukemia (AML) that has either returned after treatment or did ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

NCT ID: NCT06532084

This clinical trial is looking at a medication called sorafenib to see if it can help prevent the return of certain serious blood cancers, like acute myeloid leukemia and myelodysplastic syndromes,...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Petersburg, , Russian Federation

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT ID: NCT05546580

This clinical trial is investigating a new treatment combination for patients with relapsed or refractory acute myeloid leukemia (AML) that has a specific genetic mutation known as FLT3. The study ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Morgantown, West Virginia, United States +14 more

An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia

NCT ID: NCT06281847

This clinical trial is studying a new treatment called CCTx-001 for adults with relapsed or refractory acute myeloid leukemia (AML), a type of blood cancer that has returned or hasn’t responded to ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Stockholm, , Sweden, Ulm, , Germany +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions